Participants 35 74 3
BRAF mutation in stage III colon cancer
Participants 448 484 5
patients with stage III colon cancer
Participants 561 649 7
506 stage III colon cancer patients enrolled in a randomized adjuvant chemotherapy trial
Participants 930 983 4
431 BRAF wild-type patients, 75 BRAF-mutated patients
